Alba Therapeutics Corp.
Biopharma firm focused on zonulin pathway closes $30M financing
Published in Lab Business Week, September 25th, 2005
SV Life Sciences led the investment round together with Alta Partners and are joined by HealthCap, Red Abbey Venture Partners and the Maryland Venture Fund. Additional participants in the round include existing investors Esperance BioVentures, Astellas Ventures, Maryland TEDCO, and Townsend Capital.
"This financing brings together an international group of investors committed to advancing the company's lead product candidate, AT-1001, through proof-of-concept in humans," said Lutz Giebel, PhD, Venture Partner of SV Life Sciences. "The company has made outstanding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-09-25)
More Articles from Lab Business Week
- 4SC AG
New chief financial officer named at cheminformatics pharma firm - 7TM Pharma
Obesity drug developer adds new member to its investor group - AVANIR Pharmaceuticals
Eric Brandt named president, CEO of chronic disease-focused pharma - Allon Therapeutics
Alzheimer drug maker reports clinical update, $0.05 per share loss - America Oriental Bioengineering
Chinese pharmaceutical company generates 98.2% increase in revenue - Ariad Pharmaceuticals
Oncology drug maker raises $8.1M through sale of common stock - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
